Ian M. Mawer

Statistics

Publications

Citations

730

H-Index

Active since

1987

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Ian M. Mawer is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, glycine receptors, and glycinergic neurotransmission.

Publications per year

1987–1998

Publications

3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D4 Receptor

Janusz J. Kulagowski, Howard B. Broughton, Neil R. Curtis et al. · Journal of Medicinal Chemistry · 1996 · 257 citations · Full text

Medicine, Pharmacology, Neurochemistry +4

3-Nitro-3,4-dihydro-2(1H)-quinolones. Excitatory amino acid antagonists acting at glycine-site NMDA and (RS)-.alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors

Robert W. Carling, Paul D. Leeson, Kevin W. Moore et al. · Journal of Medicinal Chemistry · 1993 · 95 citations · Full text

Medicine, Neuroscience, Pharmacology +17

The total synthesis of myo-inositol phosphates via myo-inositol orthoformate

David C. Billington, Raymond Baker, Janusz J. Kulagowski et al. · Journal of the Chemical Society Perkin Transactions 1 · 1989 · 85 citations

Life Sciences, Biochemistry, Enzymology +6

The total synthesis of myo-inositol polyphosphates

Joseph P. Vacca, S. J. DESOLMS, Joel R. Huff et al. · Tetrahedron · 1989 · 84 citations

Life Sciences, Biochemistry, Molecular Biology +10

Synthesis of myo-inositol 1-phosphate and 4-phosphate, and of their individual enantiomers

David C. Billington, Raymond Baker, Janusz J. Kulagowski et al. · Journal of the Chemical Society Chemical Communications · 1987 · 60 citations

Pharmacy, Biochemistry, Natural Product Biosynthesis +2

1–5 of 10